Literature DB >> 3709813

Antibody-mediated targeting of liposomes to red cells in vivo.

A Singhal, C M Gupta.   

Abstract

Covalent attachment of anti-rat erythrocyte F(ab')2 to liposomes specifically enhanced their binding to rat erythrocytes in vivo and reduced their uptake by the liver. Furthermore, at least 20-30% of the cell-bound liposomes delivered their contents to the cells. Besides, the liposome binding did not affect the survival time of the target cells at least up to 3 h in the blood circulation. These results demonstrate for the first time that liposomes can be successfully targeted to cells other than liver cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709813     DOI: 10.1016/0014-5793(86)80632-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Authors:  Patrick M Glassman; Elizabeth D Hood; Laura T Ferguson; Zongmin Zhao; Don L Siegel; Samir Mitragotri; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2021-09-29       Impact factor: 15.470

2.  Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice.

Authors:  M Owais; G C Varshney; A Choudhury; S Chandra; C M Gupta
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

3.  Targeted erythropoietin selectively stimulates red blood cell expansion in vivo.

Authors:  Devin R Burrill; Andyna Vernet; James J Collins; Pamela A Silver; Jeffrey C Way
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

4.  Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes.

Authors:  Sergey A Dergunov; Elizabeth A Bowles; Weston Gordon; Michael Green; August Bierman; Mary L Ellsworth; Eugene Pinkhassik; Randy S Sprague
Journal:  Biochem Biophys Rep       Date:  2015-05-30

5.  Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.

Authors:  I Uyama; K Kumai; T Yasuda; T Tagawa; K Ishibiki; M Kitajima; T Tadakuma
Journal:  Jpn J Cancer Res       Date:  1994-04

Review 6.  Liposomes for malaria management: the evolution from 1980 to 2020.

Authors:  Patrick B Memvanga; Christian I Nkanga
Journal:  Malar J       Date:  2021-07-27       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.